NeuroPace (NPCE) Shares Outstanding (2020 - 2026)
NeuroPace (NPCE) posted quarterly Shares Outstanding (Entity) of $33.9 million for Q1 2026, up 3.54% year-over-year from $32.8 million in Q1 2025, and up 1.0% quarter-over-quarter from $33.6 million in Q4 2025.
NeuroPace (NPCE) Shares Outstanding (2020 - 2026) Analysis & Trends
NeuroPace's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $33.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 3.54% year-over-year to $33.9 million; the TTM figure through Mar 2026 stood at $33.9 million (up 3.54% YoY), while the FY2025 annual figure was $33.6 million, up 11.38% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $33.9 million, up from $33.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $33.9 million in Q1 2026, with the low at $24.5 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $28.7 million (2024), against an average of $28.8 million.
- Peak annual rise in Shares Outstanding (Entity) reached 8993.31% in 2022, while the deepest fall reached 2.29% in 2022.
- NeuroPace's Shares Outstanding (Entity) stood at $25.0 million in 2022, then climbed by 11.09% to $27.8 million in 2023, then increased by 8.34% to $30.1 million in 2024, then gained by 11.38% to $33.6 million in 2025, then rose by 1.0% to $33.9 million in 2026.
- Business Quant data shows NPCE's Shares Outstanding (Entity) at $33.9 million in Q1 2026, $33.6 million in Q4 2025, and $33.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 97.60 Mn |
| 10 | NeuroPace | 476.95 Mn | 425.25 Mn | 18.91 Mn | 34.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.10 Mn |
| Mar 31, 2026 | 33.72 Mn |
| Dec 31, 2025 | 32.72 Mn |
| Sep 30, 2025 | 33.13 Mn |
| Jun 30, 2025 | 32.86 Mn |
| Mar 31, 2025 | 31.48 Mn |
| Dec 31, 2024 | 29.13 Mn |
| Sep 30, 2024 | 29.44 Mn |
| Jun 30, 2024 | 28.85 Mn |
| Mar 31, 2024 | 28.29 Mn |
| Dec 31, 2023 | 25.85 Mn |
| Sep 30, 2023 | 26.02 Mn |
| Jun 30, 2023 | 25.47 Mn |
| Mar 31, 2023 | 25.10 Mn |
| Dec 31, 2022 | 24.59 Mn |
| Sep 30, 2022 | 24.73 Mn |
| Jun 30, 2022 | 24.50 Mn |
| Mar 31, 2022 | 24.31 Mn |
| Dec 31, 2021 | 16.61 Mn |
| Sep 30, 2021 | 24.10 Mn |